Disclaimer: Note that the firm is no longer accepting cases for the anti-psychotic medication Abilify, Tylenol autism cases, Jardiance cases connected to Fournier gangrene, or any other anti-psychotic medication cases. Thank you.
Select Page

CPAP Multidistrict Litigation Has its First Judicial Hearing

Litigation
The first-class action was filed in the District of Massachusetts on June 17, 2021. The first plaintiff lung cancer case was filed in the middle district of Georgia on July 2 of 2021. The Multidistrict Litigation that was formed is MDL 3014. The appearance deadline of which was July 22, 2021. On September 30, CPAP Litigation had its first JPML hearing, which is the Judicial Panel on Multidistrict Litigation.

Qualifying Injuries
There are several qualifying injuries currently under this particular multi-district litigation. They are listed here below:
• kidney disease or damage
• liver disease or damage
• lung disease or damage
• respiratory failure
• reactive airway disease
• acute respiratory distress system
• pleural effusion
• chemical poisoning
• bladder cancer
• brain cancer
• breast cancer
• kidney cancer
• leukemia
• liver cancer
• lung cancer
• lymphatic cancer
• multiple myeloma
• non-Hodgkin’s lymphoma
• prostate cancer
• rectal cancer
• stomach cancer
• testicular cancer
• thyroid cancer
• esophageal cancer

Current Criteria
The current criteria for a plaintiff are as follows: the plaintiff must have used Phillips Resporal onyx CPAP, APAP, or BiPAP device or a mechanical ventilator; the plaintiff must have used the qualifying device for at least six months.

If you or a loved one have been injured by a CPAP device, please call us at the Michael Brady Lynch Firm at 888-585-5970.

Sources:

https://www.fda.gov/medical-devices/medical-device-recalls/philips-respironics-recalls-certain-continuous-and-non-continuous-ventilators-including-cpap
https://www.fiercebiotech.com/medtech/fda-dishes-out-class-i-label-to-philips-recall-faulty-cpap-machines-and-other-ventilators

 

Ormond Beach Abuse Investigation: Riverbend Academy

Ormond Beach Abuse Investigation: Riverbend Academy

Multidistrict litigation (MDL No. 3094) involving GLP-1 receptor agonist medications, such as Ozempic, Wegovy, and Mounjaro, is actively moving forward in the Eastern District of Pennsylvania. Plaintiffs allege that the manufacturers failed to warn users about serious health risks, including gastroparesis, intestinal blockages, and vision loss.

read more
Ozempic, Wegovy & Mounjouro MDL Lawsuit: Latest Updates

Ozempic, Wegovy & Mounjouro MDL Lawsuit: Latest Updates

Multidistrict litigation (MDL No. 3094) involving GLP-1 receptor agonist medications, such as Ozempic, Wegovy, and Mounjaro, is actively moving forward in the Eastern District of Pennsylvania. Plaintiffs allege that the manufacturers failed to warn users about serious health risks, including gastroparesis, intestinal blockages, and vision loss.

read more
PFAS Lawsuit 2025 Update: What You Should Know

PFAS Lawsuit 2025 Update: What You Should Know

The PFAS multidistrict litigation (MDL No. 2873) is moving forward in the District of South Carolina, where over 10,000 cases remain active against major manufacturers like 3M, DuPont, and BASF. While 3M reached a $10 billion settlement in 2023 to resolve water utility claims, no global settlement has been reached for individual personal injury lawsuits.

read more
Fosamax MDL Update 2025: Legal Developments and Case Status

Fosamax MDL Update 2025: Legal Developments and Case Status

Fosamax (alendronate), a widely used osteoporosis drug, remains the subject of multidistrict litigation (MDL) over allegations that it can cause serious bone injuries, including atypical femur fractures and osteonecrosis of the jaw (ONJ). Plaintiffs claim Merck failed to warn users adequately about these risks.

read more
Paragard MDL Updates: What You Should Know

Paragard MDL Updates: What You Should Know

The Paragard IUD remains the subject of a major nationwide lawsuit, with claims alleging the device breaks during removal, leading to serious injuries that the manufacturers, Teva Pharmaceuticals, allegedly failed to adequately warn consumers about. These cases have been centralized in Multidistrict Litigation (MDL) No. 2974, in the Northern District of Georgia.

read more
Understanding the Pre-Litigation Process: What to Do After a Car Accident

Understanding the Pre-Litigation Process: What to Do After a Car Accident

The time period immediately following a car accident is crucial not only for your health, but for protecting your legal rights. Prior to any lawsuits being filed, you enter the pre-litigation phase during which critical steps must be taken. Knowing what to do after an accident can make a major difference in the outcome of your personal injury claim and help preserve your right to compensation.

read more
The Car Accident Negotiation Phase

The Car Accident Negotiation Phase

The negotiation phase after a car accident is often the toughest part of resolving your claim. Insurance companies are skilled at minimizing payouts and may challenge the seriousness of your injuries, the necessity of your medical treatment, or the legitimacy of your lost wages. Getting through this process requires more than patience, it demands strong documentation and experienced legal representation.

read more
×
What Our Clients Are Saying